A novel gene 65B13 expressed specifically and transiently in dopaminergic
neuron precursor cells immediately after cell cycle exit was obtained by
the present invention. The cellular expression of 65B13 can be used as an
index to select cells that are suitable in terms of their safety,
survival rate, and network formation ability, for transplant therapy of
neurodegenerative diseases such as Parkinson's disease.